These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

105 related articles for article (PubMed ID: 27401403)

  • 1. Metformin for chemo-radio-sensitization of NSCLC.
    Tsakiridis T; Skinner H; Pond G; Swaminath A; Wright J
    Radiother Oncol; 2016 Aug; 120(2):363-4. PubMed ID: 27401403
    [No Abstract]   [Full Text] [Related]  

  • 2. Prognostic value of metformin for non-small cell lung cancer patients with diabetes.
    Xu T; Li D; He Y; Zhang F; Qiao M; Chen Y
    World J Surg Oncol; 2018 Mar; 16(1):60. PubMed ID: 29558957
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Metformin as a repurposed therapy in advanced non-small cell lung cancer (NSCLC): results of a phase II trial.
    Parikh AB; Kozuch P; Rohs N; Becker DJ; Levy BP
    Invest New Drugs; 2017 Dec; 35(6):813-819. PubMed ID: 28936567
    [TBL] [Abstract][Full Text] [Related]  

  • 4. NLK functions to maintain proliferation and stemness of NSCLC and is a target of metformin.
    Suwei D; Liang Z; Zhimin L; Ruilei L; Yingying Z; Zhen L; Chunlei G; Zhangchao L; Yuanbo X; Jinyan Y; Gaofeng L; Xin S
    J Hematol Oncol; 2015 Oct; 8():120. PubMed ID: 26503334
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Targeting DNA Damage Response in the Radio(Chemo)therapy of Non-Small Cell Lung Cancer.
    Li L; Zhu T; Gao YF; Zheng W; Wang CJ; Xiao L; Huang MS; Yin JY; Zhou HH; Liu ZQ
    Int J Mol Sci; 2016 May; 17(6):. PubMed ID: 27258253
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Metformin for non-small cell lung cancer patients: Opportunities and pitfalls.
    Levy A; Doyen J
    Crit Rev Oncol Hematol; 2018 May; 125():41-47. PubMed ID: 29650275
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Metformin Sensitizes Non-small Cell Lung Cancer Cells to an Epigallocatechin-3-Gallate (EGCG) Treatment by Suppressing the Nrf2/HO-1 Signaling Pathway.
    Yu C; Jiao Y; Xue J; Zhang Q; Yang H; Xing L; Chen G; Wu J; Zhang S; Zhu W; Cao J
    Int J Biol Sci; 2017; 13(12):1560-1569. PubMed ID: 29230104
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Metformin increases antitumor activity of MEK inhibitors through GLI1 downregulation in LKB1 positive human NSCLC cancer cells.
    Della Corte CM; Ciaramella V; Di Mauro C; Castellone MD; Papaccio F; Fasano M; Sasso FC; Martinelli E; Troiani T; De Vita F; Orditura M; Bianco R; Ciardiello F; Morgillo F
    Oncotarget; 2016 Jan; 7(4):4265-78. PubMed ID: 26673006
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Synergistic effects of metformin in combination with EGFR-TKI in the treatment of patients with advanced non-small cell lung cancer and type 2 diabetes.
    Chen H; Yao W; Chu Q; Han R; Wang Y; Sun J; Wang D; Wang Y; Cao M; He Y
    Cancer Lett; 2015 Dec; 369(1):97-102. PubMed ID: 26341687
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Survival benefit associated with metformin use in inoperable non-small cell lung cancer patients with diabetes: A population-based retrospective cohort study.
    Chuang MC; Yang YH; Tsai YH; Hsieh MJ; Lin YC; Lin CK; Chen PC; Yang TM
    PLoS One; 2018; 13(1):e0191129. PubMed ID: 29329345
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Metformin Enhances the Therapy Effects of Anti-IGF-1R mAb Figitumumab to NSCLC.
    Cao H; Dong W; Qu X; Shen H; Xu J; Zhu L; Liu Q; Du J
    Sci Rep; 2016 Aug; 6():31072. PubMed ID: 27488947
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Co-delivery of polymeric metformin and cisplatin by self-assembled core-membrane nanoparticles to treat non-small cell lung cancer.
    Xiong Y; Zhao Y; Miao L; Lin CM; Huang L
    J Control Release; 2016 Dec; 244(Pt A):63-73. PubMed ID: 27840166
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Synergistic effects of metformin treatment in combination with gefitinib, a selective EGFR tyrosine kinase inhibitor, in LKB1 wild-type NSCLC cell lines.
    Morgillo F; Sasso FC; Della Corte CM; Vitagliano D; D'Aiuto E; Troiani T; Martinelli E; De Vita F; Orditura M; De Palma R; Ciardiello F
    Clin Cancer Res; 2013 Jul; 19(13):3508-19. PubMed ID: 23695170
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Neuropilin 1 expression correlates with the Radio-resistance of human non-small-cell lung cancer cells.
    Dong JC; Gao H; Zuo SY; Zhang HQ; Zhao G; Sun SL; Han HL; Jin LL; Shao LH; Wei W; Jin SZ
    J Cell Mol Med; 2015 Sep; 19(9):2286-95. PubMed ID: 26147006
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Metformin Triggers Autophagy to Attenuate Drug-Induced Apoptosis in NSCLC Cells, with Minor Effects on Tumors of Diabetic Patients.
    Xiao Z; Gaertner S; Morresi-Hauf A; Genzel R; Duell T; Ullrich A; Knyazev PG
    Neoplasia; 2017 May; 19(5):385-395. PubMed ID: 28391030
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Impact of H3K27 Demethylase Inhibitor GSKJ4 on NSCLC Cells Alone and in Combination with Metformin.
    Watarai H; Okada M; Kuramoto K; Takeda H; Sakaki H; Suzuki S; Seino S; Oizumi H; Sadahiro M; Kitanaka C
    Anticancer Res; 2016 Nov; 36(11):6083-6092. PubMed ID: 27793936
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Metformin in lung cancer: rationale for a combination therapy.
    Morgillo F; Sasso FC; Della Corte CM; Festino L; Manzo A; Martinelli E; Troiani T; Capuano A; Ciardiello F
    Expert Opin Investig Drugs; 2013 Nov; 22(11):1401-9. PubMed ID: 23937224
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Survival of patients with stage IV lung cancer with diabetes treated with metformin.
    Lin JJ; Gallagher EJ; Sigel K; Mhango G; Galsky MD; Smith CB; LeRoith D; Wisnivesky JP
    Am J Respir Crit Care Med; 2015 Feb; 191(4):448-54. PubMed ID: 25522257
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Combination of 2-deoxy d-glucose and metformin for synergistic inhibition of non-small cell lung cancer: A reactive oxygen species and P-p38 mediated mechanism.
    Hou XB; Li TH; Ren ZP; Liu Y
    Biomed Pharmacother; 2016 Dec; 84():1575-1584. PubMed ID: 27825799
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A Multicenter Double-blind Phase II Study of Metformin With Gefitinib as First-line Therapy of Locally Advanced Non-Small-cell Lung Cancer.
    Li KL; Li L; Zhang P; Kang J; Wang YB; Chen HY; He Y
    Clin Lung Cancer; 2017 May; 18(3):340-343. PubMed ID: 28065465
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.